Acute rheumatic fever remains a serious healthcare concern for the majority of the world’s population despite its decline in incidence in Europe and North America. This statement reviews the historic Jones criteria used to diagnose acute rheumatic fever in the context of the current epidemiology of the disease and updates those criteria to also taking into account the […]
Top 10 Cardiology Articles of the week (02.03.2015-08.03.2015) 1. Low-Level Transcutaneous Electrical Vagus Nerve Stimulation (LLTS) Suppresses Atrial Fibrillation Conclusion: LLTS suppresses AF and decreases inflammatory cytokines in patients with paroxysmal AF. The results support the emerging paradigm of neuromodulation to treat AF. 2. Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome:A 20-Year Single-Center Experience Background: Patients […]
Top 10 Cardiology Articles of the week (24.11.14 – 30.11.14) 1. Transcatheter Closure of Large Atrial Septal Defects: Feasibility and Safety in a Large Adult and Pediatric Population Conclusions—Closure of large atrial septal defects using the Amplatzer device is safe and effective in both adults and children. Superior and posterior rim deficiencies are associated with […]
Top 10 Cardiology Articles of the week (17.11.14-23.11.14) 1. A Polypill Strategy to Improve Adherence:Results From the FOCUS Project Compared with the 3 drugs given separately, the use of a polypill strategy met the primary endpoint for adherence for secondary prevention following an acute MI 2. Six-month versus […]
Top 10 Cardiology articles of the week (10.11.14-16.11.14) Hello friends , I have been busy for sometime. Now journal scan is back again after a brief interruption. I have chosen articles on general cardiology and interventional cardiology 1. The optimal management of anti-thrombotic therapy after valve replacement: […]
Meta-analysis Confirms Benefits of FFR-Guided Revascularization – Journal News – TCTMD.
A new class of drug (Neprilysin inhibitor ) when combined with angiotensin receptor blocker , has been shown to be better than Enalapril. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure — NEJM.
HPS2-THRIVE trial Among patients with atherosclerotic vascular disease, the addition of extended-release niacin–laropiprant to statin-based LDL cholesterol–lowering therapy did not significantly reduce the risk of major vascular events but did increase the risk of serious adverse events. Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients — NEJM.
1.Comprehensive Analysis of Mortality Among Patients Undergoing TAVR: Results of the PARTNER Trial J Am Coll Cardiol. 2014;64(2):158-168 2. Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina Lipids Health Dis. 2014; 13: 89 3.Association Between Intensification of Metformin Treatment With Insulin vs […]
1. Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy : The PREVAIL Trial. In this trial, LAA occlusion was noninferior to warfarin for ischemic stroke prevention […]